{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:00:51Z","timestamp":1773403251197,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jneuroim.2010.11.010","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T04:29:39Z","timestamp":1294374579000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Enhanced complement consumption in neuromyelitis optica and Beh\u00e7et's disease patients"],"prefix":"10.1016","volume":"233","author":[{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"K\u00fcrt\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recai","family":"T\u00fcrko\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"\u0130\u00e7\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fcnevver","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mer","family":"Biri\u015fik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mefk\u00fcre","family":"Eraksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsen","family":"Akman-Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.11.010_bb0005","first-page":"123","article-title":"C9 and factor B as acute phase proteins and their diagnostic and prognostic value in disease","volume":"5","author":"Adinolfi","year":"1988","journal-title":"Exp. Clin. Immunogenet."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/39.2.189","article-title":"Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis","volume":"39","author":"Aggarwal","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0015","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ocii.12.1.53.28062","article-title":"The demonstration of serum interleukin 6\u20138, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Beh\u00e7et's disease with ocular involvement","volume":"12","author":"Bardak","year":"2004","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0030","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1007\/s10072-003-0170-7","article-title":"Inflammation and degeneration in multiple sclerosis","volume":"24","author":"Br\u00fcck","year":"2003","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(02)00043-6","article-title":"Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile","volume":"197","author":"de Seze","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0040","first-page":"23","article-title":"Serum and cerebrospinal fluid C2 in multiple sclerosis","volume":"6","author":"Delasnerie-Laupretre","year":"1981","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-2-1","article-title":"Differential regulation of Abeta42-induced neuronal C1q synthesis and microglial activation","volume":"2","author":"Fan","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-0404.1989.tb03854.x","article-title":"Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis","volume":"80","author":"Halawa","year":"1989","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0055","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archneurol.2009.188","article-title":"Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells","volume":"66","author":"Hinson","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00207450903428970","article-title":"Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients","volume":"120","author":"\u0130\u00e7\u00f6z","year":"2010","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0065","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1984.tb07777.x","article-title":"Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis","volume":"69","author":"Jans","year":"1984","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0080","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archneur.1992.00530340101024","article-title":"Humoral and cellular immunologic study of cerebrospinal fluid in a patient with Beh\u00e7et encephalitis","volume":"49","author":"Jongen","year":"1992","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0090","first-page":"S63","article-title":"Human anti-alpha-enolase antibody in sera from patients with Beh\u00e7et's disease and rheumatologic disorders","volume":"27","author":"Lee","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/clin.1995.1131","article-title":"Complement activation during painful crisis in sickle cell anemia","volume":"76","author":"Mold","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0022-510X(87)90074-8","article-title":"Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex","volume":"78","author":"Mollnes","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(84)90298-8","article-title":"Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis","volume":"2","author":"Morgan","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0110","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1590\/S0004-282X2007000500013","article-title":"C3c intrathecal synthesis evaluation in patients with multiple sclerosis","volume":"65","author":"Padilla-Docal","year":"2007","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0115","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\"","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","article-title":"Immunopathology of secondary-progressive multiple sclerosis","volume":"50","author":"Prineas","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5223(99)70183-2","article-title":"Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation","volume":"118","author":"Rinder","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-erebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2009.07.014","article-title":"Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study","volume":"215","author":"Sabater","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/exnr.2001.7851","article-title":"Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis","volume":"174","author":"Schwab","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0145","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1128\/JVI.75.6.2604-2516.2001","article-title":"Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes","volume":"75","author":"Speth","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2249.1998.00620.x","article-title":"Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Beh\u00e7et patients","volume":"113","author":"Ta\u015f\u00e7i","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0155","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.11.010_bb0165","first-page":"256","article-title":"Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica","volume":"29","author":"Zhang","year":"2008","journal-title":"Neuro Endocrinol. Lett."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810005217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810005217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:17:41Z","timestamp":1759047461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810005217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0165572810005217"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.11.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced complement consumption in neuromyelitis optica and Beh\u00e7et's disease patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}